President Donald Trump is backing off a flavored vape ban. Advisers to the president said he was no longer interested in the proposed ban because it may alienate his voters and lead to job losses. Trump previously backed a federal ban on flavored vapes. (New York Times)

California has sued Juul for marketing e-cigarettes to teens. The state is the second to sue the company; North Carolina filed a similar lawsuit in May. California’s suit argues that the company’s marketing efforts used tactics to attract underage users. (Associated Press)

Pfizer has won approval for its Humira biosimilar. The drug, Abrilada, is set to hit the market in late 2023, after AbbVie’s patent on Humira, its top-selling drug, expires. It is the 25th biosimilar that the Food and Drug Administration has approved. (Endpoints)

Free HIV tests mailed to people’s homes have helped to detect more cases. A government study sent in-home HIV tests to high-risk men and found that method detected more cases than requiring a visit to a clinic to be tested. (Associated Press)

Merck and Bayer’s heart failure drug has succeeded in a late-stage study. The treatment, when combined with other available therapies, reduced the risk of hospitalization or death from heart failure in certain patients. (Reuters)